ClinicalTrials.gg
Not yet recruitingNCT07139613Updated Aug 24, 2025

We Will Assess Zirconia Crown Restoring Endodontically Treated Posterior Teeth With Two Finish Line Designs and Two Occlusal Reduction Schemes

An interventional study of Control group(PS)Planer occlusal scheme with rounded shoulder finish line and First intervention group(FF) flat occlusal scheme with feather edge finish line in Zirconia Crowns, sponsored by Armed Forces Institute of Dentistry, Pakistan. Not yet recruiting at 2 sites in Pakistan. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-24.

Sponsored by Armed Forces Institute of Dentistry, Pakistan · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Endodontically treated posterior teeth will be restored with zirconia crowns with two finish line designs(feather edge and rounded shoulder) and two occlusal reduction schemes(flat and planer).The crowns were designed with exocad software program .After cementation clinical performance in terms of marginal adaptation ,marginal discoloration, fracture and secondary caries was evaluated at 3 subsequent follow-up visits every 3months for 1 year.

Read the detailed description

Endodontically treated posterior teeth require full coverage coronal restoration, as they are more prone to fracture as compared to vital teeth .Over past two decades restorative dentistry there has been a paradigm shift in restorative dentistry towards monolithic zirconia crowns because of its superior esthetics ,excellent biocompatibility ,and continually improving biomechanical properties. For the long term clinical success of zirconia crowns tooth preparation designs particularly finish line designs and occlusal reduction play significant role. Different finish lines designs such as chamfer and shoulder, play a role in marginal fit of restoration .While assessing zirconia crowns of two finish line designs and two occlusal reduction schemes the participants were divided into three groups based on preparation design: the control group PS (planer occlusal and rounded shoulder) ; first interventional group (flat occlusal and feather); Second interventional group (flat occlusal and rounded shoulder) .To minimize bias the outcome assessor ,participants and statistician were blinded and only investigator will not blinded. After cementation on subsequent follow-up of one year with every three months interval United states Public Health Services Criteria (USPHS) is used for marginal adaptation ,discoloration, fracture and secondary caries, and gingival index score system is used for gingival response.

Second interventional group FS (Flat occlusal + rounded shoulder)

02

Conditions studied

  • Zirconia Crowns

Keywords

  • Zirconia crowns assessment with two finish line design and two occlusal reduction schemes
03

In context

Lead sponsor

Armed Forces Institute of Dentistry, Pakistan is the lead sponsor of 27 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients from both genders.
  • age range 18-65 years.
  • patients with endodontically treated posterior teeth.

Exclusion criteria

Exclusion Criteria:

  • vital teeth
  • anterior teeth.
  • edentulous patient.
  • patient with history of significant systemic diseases.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
66 participants (estimated)

Study arms

  • Active comparator
    Control group (PS)

    Other: Control group(PS)Planer occlusal scheme with rounded shoulder finish line

  • Experimental
    First intervention group (FF)flat occlusal scheme with feather-edge finish line

    In this intervention group flat occlusal scheme and feather edge finish line design is followed

    Procedure: First intervention group(FF) flat occlusal scheme with feather edge finish line

  • Experimental
    Second intervention group (FS)flat occlusal scheme with rounded shoulder finish line

    Procedure: Second intervention group(FS) flat occlusal with rounded shoulder finish line design

Interventions

  • OtherControl group(PS)Planer occlusal scheme with rounded shoulder finish line

    Control group (PS) will have planer occlusal scheme with rounded shoulder finish line.

  • ProcedureFirst intervention group(FF) flat occlusal scheme with feather edge finish line

    First intervention group we will have flat occlusal scheme with feather edge finish line

  • ProcedureSecond intervention group(FS) flat occlusal with rounded shoulder finish line design

    Second intervention will have flat occlusal scheme with rounded shoulder finish line design

06

What researchers measure

Primary outcomes

  1. Gingival index score system and United States Public Health Services Criteria(USPHS)

    Marginal adaptation ,marginal discoloration ,fracture and secondary caries evaluated using (USPHS) United States Public Health Services Criteria and gingival index score system is used to evaluate gingival response.

    Time frame: One year

07

Study locations

2 sites
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Aug 2025; primary completion for Aug 2026, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 18, 2025
First posted
Aug 24, 2025
StartEst.
Aug 2025
Primary completionEst.
Aug 2026
CompletionEst.
Oct 2026
Last update
Aug 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07139613
Lead sponsor
Armed Forces Institute of Dentistry, Pakistan
Responsible party
Saira Bibi (Registrar prosthodontics, Armed Forces Institute of Dentistry, Pakistan) — Principal investigator
First posted
Aug 24, 2025
Start date
Aug 2025 (estimated)
Primary completion
Aug 2026 (estimated)
Completion
Oct 2026 (estimated)
Last update
Aug 24, 2025

Study contacts

Saira Bibi
Contact
drbibisaira@gmail.com
+923481923065

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion